Exploring the utility of TP53 mutations as prognostic markers in patients with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Wang, Y. [1 ]
Zuo, J. [1 ]
Feng, L. [1 ]
Fan, Z. [1 ]
Wang, L. [1 ]
Zhang, X. [1 ]
Han, J. [1 ]
Zhou, X. [1 ]
Ye, J. [2 ]
Li, B. [2 ]
Lizaso, A. [2 ]
Zhou, J. [2 ]
机构：
[1] Hebei Med Univ, Hosp 4, Med Oncol, Shijiazhuang, Hebei, Peoples R China
[2] Burning Rock Biotech, Med, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1431
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1229P
引用
收藏
页码：S799 / S800
页数：2
相关论文
共 50 条
  • [1] TP53 Mutations in Korean Patients with Non-small Cell Lung Cancer
    Lee, Eung Bae
    Jin, Guang
    Lee, Shin Yup
    Park, Ji Young
    Kim, Min Jung
    Choi, Jin Eun
    Jeon, Hyo Sung
    Cha, Seung Ick
    Cho, Sukki
    Kim, Chang Ho
    Park, Tae-In
    Jung, Tae Hoon
    Son, Ji-Woong
    Park, Jae Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (05) : 698 - 705
  • [2] Prognostic Value of TP53 Hot Exon Mutation in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    He, Y.
    Guo, R.
    Liu, Y.
    Xu, F.
    Wang, Y.
    Cao, J.
    Wu, Q.
    Han, Z.
    Ye, J.
    Zhang, L.
    Mao, X.
    Zhang, Z.
    Liu, J.
    Zhang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S681 - S682
  • [3] Characterization of TP53 mutations in actionable driver-negative non-small cell lung cancer (NSCLC)
    Chi, Jie
    Gandhi, Nishant
    Halmos, Balasz
    Liu, Stephen V.
    Ma, Patrick C.
    Elliott, Andrew
    Vanderwalde, Ari M.
    Mamdani, Hirva
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Effects of Tp53 Gene Mutations on the Survival of Non-Small Cell Lung Cancer (NSCLC); A Short Review
    Zhang, Chi
    Yang, Chao
    Shi, Qingming
    CANCER MANAGEMENT AND RESEARCH, 2025, 17 : 65 - 82
  • [5] Effect of TP53 co-mutation in non-small cell lung cancer (NSCLC) with driver mutations
    Feng, J.
    Hueniken, K.
    Fan, Z.
    Faour, E.
    Corke, L.
    Leighl, N.
    Liu, G.
    Bradbury, P.
    Sacher, A.
    Eng, L.
    Stockley, T.
    Tsao, M-S.
    Shepherd, F. A.
    ANNALS OF ONCOLOGY, 2023, 34
  • [6] Prognostic and predictive effects of TP53 mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
    Labbe, Catherine
    Korpanty, Grzegorz
    Tomasini, Pascale
    Doherty, Mark
    Mascaux, Celine
    Jao, Kevin
    Pitcher, Bethany
    Pintilie, Melania
    Leighl, Natasha B.
    Feld, Ronald
    Liu, Geoffrey
    Bradbury, Penelope Ann
    Kamel-Reid, Suzanne
    Tsao, Ming Sound
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Frequency of somatic TP53 mutations in non-small cell lung cancer in Kazakhstan
    Zhuraliyeva, A.
    Wang, J.
    Khamdiyeva, O.
    Abdullaev, Z.
    Pack, S.
    Biyasheva, Z.
    FEBS OPEN BIO, 2019, 9 : 354 - 354
  • [8] Predictive value of coexisting KRAS and TP53 mutations on response to chemotherapy in non-small cell lung cancer (NSCLC).
    Tomasini, Pascale
    Jao, Kevin
    Kamel-Reid, Suzanne
    Stockley, Tracy
    Tsao, Ming Sound
    Liu, Geoffrey
    Leighl, Natasha B.
    Feld, Ronald
    Bradbury, Penelope Ann
    Pintilie, Melania
    Mascaux, Celine
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Poor prognosis of concurrent KRAS and TP53 mutations in patients with resected non-squamous non-small cell lung cancer (NSCLC)
    Pecuchet, N.
    Laurent-Puig, P.
    Pallier, K.
    Le Pimpec-Barthes, F.
    Riquet, M.
    Cazes, A.
    Fabre, E.
    Blons, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S813 - S813
  • [10] Impact of TP53 mutations on efficacy of PD-1 targeted immunotherapy in non-small cell lung cancer (NSCLC).
    Carlisle, Jennifer Wilkinson
    Nhu Thi Nho
    Kim, Chaejin
    Chen, Zhengjia
    Li, Shiyong
    Hill, Charles
    Ramalingam, Suresh S.
    Sica, Gabriel
    Owonikoko, Taofeek Kunle
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345